EDQM-Approved Catechins for PharmaceuticalApplications: Comprehensive EP 10.0 & CEP Compliance
Blue Eyes Biotech Co., Ltd manufacturespharmacopeial-grade Camellia sinensis extract under EU GMP Annex 1 guidelines,delivering rigorously standardized tea catechins (>98% total polyphenols)that satisfy European Pharmacopoeia 10.0 monograph requirements for criticaldrug formulations.
Regulatory Excellence:
- CEP Active: EDQM Certification ofSuitability (CEP No. XYZ123) covering chemical/biological profiles
- EP 10.0 Conformity: Validated methods forcatechins quantification (HPLC-UV per 2.2.29)
- ICH Q7 Compliance: Class D cleanroom isolationwith <ISO 5 particle control
Critical Quality Attributes:
- Endotoxin Control: <0.25 EU/mg (LALtest per EP 2.6.14) for injectableapplications
- Elemental Impurities: Meets ICH Q3DOption 1 limits (As<1.5ppm, Cd<0.5ppm)
- Polymorphic Stability: XRD-confirmedamorphous structure preventing crystallization
- Residual Solvents: Class 2/3 solventsundetectable (GC-MS <10ppm)
Application-Specific Validation:
▶️ Cardiovascular Drugs:
- Batch consistency in dissolution profiles(f2>85 per FDA SUPAC-IR)
- Oxidation stability under acceleratedconditions (40°C/75% RH)
▶️ Oncology Adjuvants:
- Sterile filtration validation (0.22μmPVDF membrane compatibility)
- Radiolytic sterilization compatibilitydata
▶️ Nutraceutical Excipients:
- TSE/BSE risk-free documentation (EC999/2001 compliant)
- Allergen-free manufacturing
Documentation Suite Includes:
- CEP Dossier Modules 3.2.S &3.2.P
- Process Validation Protocols (PPQ Lot: BEB-2024-CTP)
- Extractables/Leachables study forparenteral packaging
- 36-month ICH Q1A(R2) stabilitycommitment
Procurement Advantage:
- Audit-ready EDQM/GMP documentation
- Small-batch production (MOQ 5kg forclinical trials)
- Cold-chain global logistics with QPdeclaration
Download EP 10.0 Gap Analysis:www.blueeyes-bio.com
Request CEP Draft Review:[email protected]